The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ramucirumab in pediatric and young adult patients (Pts) with relapsed/refractory (R/R) desmoplastic small round cell tumor (DSRCT) or synovial sarcoma (SS): Results from the CAMPFIRE study.
 
Emily Slotkin
Consulting or Advisory Role - Guidepoint Global; Inhibrx
Research Funding - Esperas Pharma; Lilly (Inst); Lilly (Inst)
 
Michela Casanova
Consulting or Advisory Role - Alexion Pharmaceuticals (Inst); AstraZeneca; Bayer; Roche/Genentech; Servier
 
Brian Van Tine
Leadership - Polaris
Honoraria - Beijing Biostar Pharmaceuticals Co., Ltd.; Oncology Education; Total Health Conference
Consulting or Advisory Role - Aadi; Acuta Capital Partners, LLC; Adaptimmune; Advenchen Laboratories; Boxer Capital LLC; Crisper Therapeutics; Daiihi Sankyo; Deciphera; Galapagos NV; Hinge Bio; Kronos Bio, Inc.; Putnam Associates; Salarius Pharmaceuticals, INc.; Syneos Health
Research Funding - Polaris
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Kronos Bio, Inc
 
Sandra Strauss
Consulting or Advisory Role - Boehringer Ingelheim; Ceridwen Oncology; GlaxoSmithKline; InhibRx; Tessallate Bio
Speakers' Bureau - Boehringer Ingelheim
Travel, Accommodations, Expenses - Adaptimmune
 
Spyridon Gennatas
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo UK; Merck Sharp and Dohme
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Roche
 
Ayumu Arakawa
Honoraria - Abbvie; Chugai Pharma; Lilly; Ohara Pharmaceutical; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Takeda (Inst)
 
Julia Chisholm
Consulting or Advisory Role - Bayer; Bayer; Roche; Roche/Genentech
Research Funding - Bayer (Inst)
Other Relationship - Children's Oncology Group; National Cancer Institute
 
Claudia Valverde Morales
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Deciphera; PharmaMar; Philogen
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Alexia Bertuzzi
Honoraria - Lilly
 
Alok Kothari
No Relationships to Disclose
 
Martin McCabe
Research Funding - Eisai (Inst)
 
Simone Hettmer
No Relationships to Disclose
 
Theodore Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Consulting or Advisory Role - AI Therapeutics; Bayer; GlaxoSmithKline; ITM Oncologics; Jazz Pharmaceuticals
Research Funding - Adaptimmune (Inst); Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); BioAtla (Inst); Exelixis (Inst); ITM Oncologics (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Oncology (Inst); Turning Point Therapeutics (Inst)
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst); Recordati
 
Utako Oba
No Relationships to Disclose
 
Uwe Kordes
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca
 
Adams Appiah
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Kamnesh Pradhan
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
Other Relationship - Lilly
 
Andrea Ferrari
No Relationships to Disclose
 
CAMPFIRE Study Team
No Relationships to Disclose